MedPath

The effect of Lavandula Angustifolia, Echium amoenum, and Melissa officinalis in comparison with sertraline in the treatment of mild to moderate depression in older adults

Phase 3
Conditions
Depression.
Other depressive episodes
F32.8
Registration Number
IRCT20140617018126N5
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
120
Inclusion Criteria

Age over 60 years
People referring to a psychiatrist with mild to moderate depression who have a depression score of 18 to 24 in the Hamilton questionnaire

Exclusion Criteria

No use of antidepressants and antipsychotics and mood-stabilizing nutrients four weeks before the clinical trial
Having suicidal ideation
Symptoms of major depression
Alcohol use in the past 12 months
Warfarin and phenytoin use
People who have just started psychotherapy
People who are pregnant and lactation
Taking birth control pills
Substance abuse
Biological and physical factors such as head trauma, hypothyroidism, dementia, bipolar spectrum, and psychoses
Receiving ECT

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depression. Timepoint: The first, second, fourth and eighth weeks. Method of measurement: Hamilton Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath